R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Pharmacy and clinical research: the pharmaphorum podcast

In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of RxE2.

Digital

Blockchain: Ready to revolutionise medicinal cannabis resear...

Robert Galarza outlines how blockchain technology can be utilised to verify, validate and standardise the efficacy of medical cannabis and oth

R&D

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

Renal disease: the big picture

Renal diseases represent a formidable challenge on public health systems around the world.

Views & Analysis

Towards a new understanding of cardiovascular risk in diabetes

Is cardiovascular disease a ‘pandemic hiding in plain sight’...

Amarin’s Craig Granowitz discusses the impact of COVID on cardiovascular disease treatment and explains why there’s still a long way to go till we can truly tackle these diseases.<

Views & Analysis

How can the pharma industry help build a greener NHS?

NHS England has set its sights on becoming the world’s first net zero health system by 2045 – so what is industry doing to help achieve this goal, and what more needs to be done? <

Views & Analysis